{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:57:50Z","timestamp":1795021070019,"version":"4.10.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,15]]},"DOI":"10.1093\/jnci\/djt235","type":"journal-article","created":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T03:31:12Z","timestamp":1380943872000},"page":"1550-1557","source":"Crossref","is-referenced-by-count":193,"title":["Screening for Cervical Cancer Precursors With p16\/Ki-67 Dual-Stained Cytology: Results of the PALMS Study"],"prefix":"10.1093","volume":"105","author":[{"given":"Hans","family":"Ikenberg","sequence":"first","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bergeron","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Griesser","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Alameda","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Angeloni","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bogers","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dachez","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Denton","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Hariri","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Keller","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"von Knebel Doeberitz","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich H.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Puig-Tintore","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sideri","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rehm","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruediger","family":"Ridder","sequence":"additional","affiliation":[{"name":"Affiliations of authors: Cytomol, Frankfurt, Germany (HI); Laboratoire Cerba, Cergy Pontoise, France (CB); Institute for Pathology, Mannheim, Germany (DS); Center for Pathology and Cytodiagnostics, Cologne, Germany (HG); Hospital del Mar, Barcelona, Spain (FA); Unit\u00e0 Gestionale Screening Regionale, Ospedale Atri, Italy (CA); Labo Lokeren - Campus Riatol, Antwerp, Belgium (JB); Institute Alfred Fournier, Paris, France (R"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PALMS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"issue":"10","key":"key\n\t\t\t\t20180328171626_CIT0001","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"issue":"5","key":"key\n\t\t\t\t20180328171626_CIT0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20180328171626_CIT0003","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"key\n\t\t\t\t20180328171626_CIT0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"issue":"9601","key":"key\n\t\t\t\t20180328171626_CIT0005","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkman","year":"2007","journal-title":"Lancet"},{"issue":"16","key":"key\n\t\t\t\t20180328171626_CIT0006","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"issue":"16","key":"key\n\t\t\t\t20180328171626_CIT0007","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20180328171626_CIT0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t20180328171626_CIT0009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20180328171626_CIT0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"11\u201312","key":"key\n\t\t\t\t20180328171626_CIT0011","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.exger.2004.06.025","article-title":"Ink4a\/ARF links senescence and aging","volume":"39","author":"Sharpless","year":"2004","journal-title":"Exp Gerontol"},{"issue":"4","key":"key\n\t\t\t\t20180328171626_CIT0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1155\/2007\/678793","article-title":"Biomarkers in cervical cancer screening","volume":"23","author":"Wentzensen","year":"2007","journal-title":"Dis Markers"},{"issue":"10","key":"key\n\t\t\t\t20180328171626_CIT0013","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1055-9965.EPI-08-0306","article-title":"Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia","volume":"17","author":"Cuschieri","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"key\n\t\t\t\t20180328171626_CIT0014","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.21205","article-title":"p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis","volume":"120","author":"Roelens","year":"2012","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"key\n\t\t\t\t20180328171626_CIT0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(08)70208-0","article-title":"Use of p16INK4a overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomized controlled trial","volume":"9","author":"Carozzi","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"key\n\t\t\t\t20180328171626_CIT0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","article-title":"Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4a results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial","volume":"14","author":"Carozzi","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"key\n\t\t\t\t20180328171626_CIT0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/Ki-67 Dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European Equivocal or Mildly Abnormal Pap Cytology Study (EEMAPS)","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"key\n\t\t\t\t20180328171626_CIT0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"key\n\t\t\t\t20180328171626_CIT0019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1309\/AJCP00INMGIFYFNQ","article-title":"CINtec PLUS immunocytochemistry as a tool for the cytologic diagnosis of glandular lesions of the cervix uteri","volume":"138","author":"Ravarino","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"key\n\t\t\t\t20180328171626_CIT0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cncy.20188","article-title":"Immunocytochemical colocalization of p16(INK4a) and Ki-67 predicts CIN2\/3 and AIS\/adenocarcinoma","volume":"120","author":"Singh","year":"2012","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"key\n\t\t\t\t20180328171626_CIT0021","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncy.21233","article-title":"Evaluation of p16(INK4a)\/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion [published online ahead of print September 17, 2012]","volume":"121","author":"Waldstr\u00f8m","year":"2013","journal-title":"Cancer Cytopathol"},{"issue":"15","key":"key\n\t\t\t\t20180328171626_CIT0022","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"16","key":"key\n\t\t\t\t20180328171626_CIT0023","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system. Terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328171626_CIT0024","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction","author":"Pepe","year":"2003"},{"issue":"1","key":"key\n\t\t\t\t20180328171626_CIT0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2307\/2530820","article-title":"Assessment of diagnostic tests when disease verification is subject to selection bias","volume":"39","author":"Begg","year":"1983","journal-title":"Biometrics"},{"issue":"3","key":"key\n\t\t\t\t20180328171626_CIT0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/sim.1959","article-title":"Verification bias-corrected estimators of the relative true and false positive rates of two binary screening tests","volume":"24","author":"Alonzo","year":"2005","journal-title":"Stat Med"},{"issue":"2","key":"key\n\t\t\t\t20180328171626_CIT0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(12)70568-5","article-title":"Triage of HPV-positive women in cervical cancer screening","volume":"14","author":"Wentzensen","year":"2013","journal-title":"Lancet Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/105\/20\/1550\/17934715\/djt235.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T12:03:21Z","timestamp":1716033801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/105\/20\/1550\/2517546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":27,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2013,10,4]]},"published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djt235","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10,15]]},"published":{"date-parts":[[2013,10,4]]}}}